Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_2265854
Proper Citation: Aviva Systems Biology Cat# ARP33683_P050, RRID:AB_2265854
Target Antigen: MAFB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)) (against the N terminal of MAFB) (50ug)
Host Organism: rabbit
Clonality: polyclonal
Comments: manufacturer recommendations: IgG Western Blot; ELISA; WB, IHC
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for MAFB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)) Antibody (against the N terminal of MAFB) (50ug).
No alerts have been found for MAFB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)) Antibody (against the N terminal of MAFB) (50ug).
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.